Literature DB >> 2153711

Regulation of macrophage function by interferon-gamma. Somatic cell genetic approaches in murine macrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and expression of the chronic granulomatous disease gene.

M Goldberg1, L S Belkowski, B R Bloom.   

Abstract

The importance of oxidative cytocidal mechanisms of phagocytic cells in immune protection against microbial pathogens is uniquely revealed by chronic granulomatous disease (CGD), a genetic deficiency disease of man. This cytocidal response in mononuclear phagocytes is principally regulated by IFN-gamma. A somatic cell genetic approach was taken to select oxidative variants from a cloned murine macrophage cell line, J774.16, which formally permitted us to dissociate three regulatory effects of IFN-gamma on these cells: the antiproliferative effect, the antiviral effect, and production of superoxide anion. Half of the variants defective in O-2 production after phorbol myristate acetate stimulation were also resistant to the antiproliferative effects of IFN-gamma. This result suggests that IFN-gamma-induced growth inhibition and production of cytocidal oxygen intermediates are mediated via a common pathway. The somatic cell genetic approach has allowed us to develop in vitro macrophage models for several forms of CGD. One variant characterized in detail, D9, was unable to produce superoxide after stimulation by phorbol esters. At the molecular level, Northern blot analysis revealed that the mRNA encoding the large subunit of the putative CGD gene product, cytochrome b558, was absent in this variant. Another class of variants constitutively unable to produce O-2 or the cytochrome b558 mRNA could be induced to do so by IFN-gamma. These somatic mutants may be useful models in clarifying the role of the CGD gene product and its regulation in the production of cytocidal oxygen intermediates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153711      PMCID: PMC296459          DOI: 10.1172/JCI114473

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

Authors:  B Holmes; A R Page; R A Good
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

2.  B cell lines as models for inherited phagocytic diseases: abnormal superoxide generation in chronic granulomatous disease and giant granules in Chediak-Higashi syndrome.

Authors:  D J Volkman; E S Buescher; J I Gallin; A S Fauci
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

3.  Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes.

Authors:  P M Guyre; P M Morganelli; R Miller
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

4.  Absence of cytochrome b-245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance.

Authors:  A W Segal; A R Cross; R C Garcia; N Borregaard; N H Valerius; J F Soothill; O T Jones
Journal:  N Engl J Med       Date:  1983-02-03       Impact factor: 91.245

5.  Growth of Trypanosoma cruzi in a cloned macrophage cell line and in a variant defective in oxygen metabolism.

Authors:  Y Tanaka; H Tanowitz; B R Bloom
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

6.  Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon.

Authors:  D P King; P P Jones
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

7.  Lymphokine enhances oxygen-independent activity against intracellular pathogens.

Authors:  H W Murray; G I Byrne; C D Rothermel; D M Cartelli
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

8.  Macrophage variants in oxygen metabolism.

Authors:  G Damiani; C Kiyotaki; W Soeller; M Sasada; J Peisach; B R Bloom
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

9.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

10.  Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.

Authors:  P S Steeg; R N Moore; H M Johnson; J J Oppenheim
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  20 in total

1.  A new cell enzyme-linked immunosorbent assay demonstrates gamma interferon suppression by beta interferon in multiple sclerosis.

Authors:  M Bakhiet; V Ozenci; C Withagen; M Mustafa; S Fredrikson; H Link
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  A lipopolysaccharide (LPS)-resistant mutant isolated from a macrophagelike cell line, J774.1, exhibits an altered activated-macrophage phenotype in response to LPS.

Authors:  F Amano; Y Akamatsu
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Suppression by human recombinant gamma interferon of in vitro macrophage nonopsonic and opsonic phagocytosis and killing.

Authors:  D P Speert; L Thorson
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 4.  The Flipside of the Power of Engineered T Cells: Observed and Potential Toxicities of Genetically Modified T Cells as Therapy.

Authors:  Felipe Bedoya; Matthew J Frigault; Marcela V Maus
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

Review 5.  Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors:  R W Ledeen; G Chakraborty
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

6.  Difference in Legionella pneumophila growth permissiveness between J774.1 murine macrophage-like JA-4 cells and lipopolysaccharide (LPS)-resistant mutant cells, LPS1916, after stimulation with LPS.

Authors:  F Kura; K Suzuki; H Watanabe; Y Akamatsu; F Amano
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.

Authors:  T Olsson; W W Zhi; B Höjeberg; V Kostulas; Y P Jiang; G Anderson; H P Ekre; H Link
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

8.  Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo.

Authors:  Luka Cicin-Sain; Wolfram Brune; Ivan Bubic; Stipan Jonjic; Ulrich H Koszinowski
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  csrT Represents a New Class of csrA-Like Regulatory Genes Associated with Integrative Conjugative Elements of Legionella pneumophila.

Authors:  Zachary D Abbott; Kaitlin J Flynn; Brenda G Byrne; Sampriti Mukherjee; Daniel B Kearns; Michele S Swanson
Journal:  J Bacteriol       Date:  2015-11-23       Impact factor: 3.490

10.  Transcriptional response of chicken embryo cells to Newcastle disease virus (D58 strain) infection.

Authors:  Ramesh Kumar; J John Kirubaharan; N Daniel Joy Chandran; N Gnanapriya
Journal:  Indian J Virol       Date:  2013-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.